Ledger.Open graph →
SEC Form D · filed February 14, 2024

Graviton BioScience Corp

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
New York, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Ran D. Nussbaum · New York, NYDirectorSamuel D. Waksal · New York, NYExec · Director · PromoterBihua Chen · San Diego, CADirectorJeremy D. Levin · New York, NYDirectorDavid D. Macmillan · New York, NYDirectorJames D. Boylan · New York, NYDirectorStelios D. Papadopoulos · New York, NYDirectorSamuel D. Waksal · New York, NYExec · Director · PromoterBihua Chen · San Diego, CADirectorJeremy D. Levin · New York, NYDirectorDavid D. Macmillan · New York, NYDirectorJames D. Boylan · New York, NYDirectorStelios D. Papadopoulos · New York, NYDirectorRan D. Nussbaum · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗